肾病综合征患者血清载脂蛋白的变化及其临床意义  

CLINICAL SIGNIFICANCE IN DETERMINING LIPID AND APOLIPOPROTEIN IN PATIENTS WITH NEPHROTIC SYNDROME

作　　者：符俏[1] 黄烈诚[1] 

机构地区：[1]海南省人民医院内科

出　　处：《海南医学院学报》1996年第4期151-153,共3页Journal of Hainan Medical University

摘　　要：对２０的肾病综合征（ＮＳ）患者的血脂和载脂蛋白（ａｐｏ）进行检测，发现ＮＳ患者治疗前后的脂代谢明显地有差别，尤以ＴＣ、ＡｐｏＢ为突出。结果表明。ＮＳ患者治疗前后测定ａｐｏ价值与测定血脂一样重要，ＡｐｏＢ是一项较为敏感的指标，且是ＮＳ患者出现肾小球硬化、动脉粥样硬化的危险因素。Blood lipid and apolipoprotein(apo) were tested in 20 cases of nephrotic syndrome,The results showed that there was a distinct difference in lipid metabolism before and after the treatment and it was even more significant in apo metabolism.It indicated, according to the study,that the determination of apo is the same as that of lipid.ApoB is more sensitive and can serve as a significant index for the diagnosis of patients with nephrotic syndrome when renal glomerular sclerosis and atherosclerosis occur.

关 键 词：肾病综合征 血脂 载脂蛋白 

分 类 号：R692.04[医药卫生—泌尿科学] R446.112[医药卫生—外科学]